Drug Approval | April 10, 2024
NATCO Pharma receives warning letter from USFDA for facility in Kothur, Telangana
The company will respond to the Warning Letter within the stipulated timelines
The company will respond to the Warning Letter within the stipulated timelines
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
More than 10,000 scientific publications containing EUDRAGIT
Connecting new production and consumption areas of chilled food by low-carbon transportation services
This agreement paves the way for the introduction of YESAFILI into the Canadian market
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
BHL will undertake the development and supply of these molecules
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Subscribe To Our Newsletter & Stay Updated
